Smith & Nephew secures US DOD contract worth up to $75m.

Smith & Nephew said on Tuesday that it has been awarded a contract worth up to $75m to provide Negative Pressure Wound Therapy systems to the US Department of Defense.

Smith & Nephew
27 May 2025 15:21:53

Source: Sharecast

The company has been selected to provide its Renasys Touch Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year contract through the Defense Logistics Agency (DLA).

It said the system will support military medical providers to administer therapy through prolonged casualty care, first surgical intervention, aeromedical transport and definitive care in military treatment facilities. Renasys Touch NPWT is manufactured in the US.

Dennis Lyons, Sr. Director Military & Federal Health for Smith & Nephew, said: "Future conflicts will be more difficult and complex. This implies medical devices and treatments will need to be simplified and more intuitive to be used farther forward by a wide range of providers.

"Renasys Touch NPWT will provide that simplified negative pressure wound therapy solution to the military care continuum for warfighters who need it most."

FTSE 100 ( UKX )

ISIN: N/A

Exchange: London Stock Exchange

Sell:

0.00

Buy:

0.00

Change: -6.07 ( -0.07 %)

Date:

29/05/2025 - 10:00

Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.